Cargando…
Mutation status of RAD51C,PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations
In addition to BRCA1 and BRCA2, RAD51C,PALB2 and BRIP1 are known as breast cancer susceptibility genes. However, the mutation status of these genes in Japanese familial breast cancer cases has not yet been evaluated. To this end, we analyzed the exon sequence and genomic rearrangement of RAD51C,PALB...
Autores principales: | Sato, Katsutoshi, Koyasu, Mio, Nomura, Sachio, Sato, Yuri, Kita, Mizuho, Ashihara, Yuumi, Adachi, Yasue, Ohno, Shinji, Iwase, Takuji, Kitagawa, Dai, Nakashima, Eri, Yoshida, Reiko, Miki, Yoshio, Arai, Masami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666035/ https://www.ncbi.nlm.nih.gov/pubmed/28796317 http://dx.doi.org/10.1111/cas.13350 |
Ejemplares similares
-
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
por: Shimada, Satoko, et al.
Publicado: (2019) -
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
por: Kuusisto, Kirsi M, et al.
Publicado: (2011) -
Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021) -
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
por: Ogrodniczak, Alicja, et al.
Publicado: (2022) -
Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
por: Wojcik, P., et al.
Publicado: (2016)